Emil Kakkis Md

Emil Kakkis, MD, PhD

EveryLife Foundation for Rare Diseases

Emil Kakkis, M.D., Ph.D. - Developing Treatments for Rare Diseases

Sanford Burnham Prebys

Emil Kakkis, MD, PhD | The Challenges of Managing Heterogeneity in Rare Diseases

EveryLife Foundation for Rare Diseases

Emil Kakkis, MD, PhD, EveryLife Foundation

EveryLife Foundation for Rare Diseases

Emil Kakkis | 2022 FAST Summit on Angelman Syndrome

FAST

Developing Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil Kakkis

WCG

Emil Kakkis - keynote lecture: Translating rare disease research into medicine

Wellcome Connecting Science Learning and Training

Time for an Ultra-Orphan Drug Act by Dr. Emil Kakkis

Cure GM1 Foundation

Developing Treatments at Ultragenyx

AngelmanSyndromeFdn

How A Doctor Helped A Young Patient With Fatal Disorder Defy Odds

Emil Kakkis, MD, PhD - Nov. 13, 2014 RDLA Caucus Briefing

EveryLife Foundation for Rare Diseases

Emil Kakkis : Master of Ceremonies

EveryLife Foundation for Rare Diseases

Translational Medicine Symposium 2013: Dr. Emil Kakkis, 3 of 4

Albert Einstein College of Medicine

2019 FAST Science Summit on Angelman Syndrome - Keynote, Dr. Emil Kakkis, Ultragenyx Pharmaceutical

FAST

FDA Approval of Crysvita® for X-linked Hypophosphatemia (XLH)

HPR

How Rare Disease Treatments Get Approved

Faster Rare Disease Progress is Within our Reach with Dr. Emil Kakkis and Mary Woolley

ResearchAmerica

Emil Kakkis M.D., Ph.D. PKU presentation at Rare Disease Workshop 3

KakkisEveryLife

Emil Kakkis, M.D., Ph.D. opening presentation at Rare Disease Workshop 3

KakkisEveryLife

Emil Kakkis, M.D., Ph.D. Urinary GAG presentation at Rare Disease Workshop 3

KakkisEveryLife